Benzinga | Aug 7, 2020 07:30AM EDT

Ocular Therapeutix Q2 EPS $(0.64) Misses $(0.31) Estimate, Sales $1.57M Beat $1.50M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.31) by 106.45 percent. This is a 12.28 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $1.57 million which beat the analyst consensus estimate of $1.50 million by 4.60 percent. This is a 141.38 percent increase over sales of $650.00 thousand the same period last year.